The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains

被引:93
作者
Dittmann, Antje [1 ]
Werner, Thilo [1 ]
Chung, Chun-Wa [2 ]
Savitski, Mikhail M. [1 ]
Savitski, Maria Faelth [1 ]
Grandi, Paola [1 ]
Hopf, Carsten [1 ]
Lindon, Matthew [3 ]
Neubauer, Gitte [1 ]
Prinjha, Rabinder K. [3 ]
Bantscheff, Marcus [1 ]
Drewes, Gerard [1 ]
机构
[1] Cellzome GmbH, D-69117 Heidelberg, Germany
[2] GlaxoSmithKline Med Res Ctr, Stevenage SG1 2NY, Herts, England
[3] GlaxoSmithKline Med Res Ctr, Epinova DPU, Stevenage SG1 2NY, Herts, England
关键词
SELECTIVE-INHIBITION; KINASE; TARGET; ACTIVATION; PROTEIN; BRD4; CHEMOPROTEOMICS; MECHANISMS; DISCOVERY; 3-KINASE;
D O I
10.1021/cb400789e
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A commonly used small-molecule probe in cell-signaling research is the phosphoinositide 3-kinase inhibitor LY294002. Quantitative chemoproteomic profiling shows that LY294002 and LY303511, a close analogue devoid of PI3K activity, inhibit the BET bromodomain proteins BRD2, BRD3, and BRD4 that comprise a family of targets structurally unrelated to PI3K. Both compounds competitively inhibit acetyl-lysine binding of the first but not the second bromodomain of BET proteins in cell extracts. X-ray crystallography shows that the chromen-4-one scaffold represents a new bromodomain pharmacophore and establishes LY294002 as a dual kinase and BET-bromodomain inhibitor, whereas LY303511 exhibits anti-inflammatory and antiproliferative effects similar to the recently discovered BET inhibitors.
引用
收藏
页码:495 / 502
页数:8
相关论文
共 36 条
[1]   Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors [J].
Bandukwala, Hozefa S. ;
Gagnon, John ;
Togher, Susan ;
Greenbaum, Jason A. ;
Lamperti, Edward D. ;
Parr, Nigel J. ;
Molesworth, Amy M. H. ;
Smithers, Nicholas ;
Lee, Kevin ;
Witherington, Jason ;
Tough, David F. ;
Prinjha, Rab K. ;
Peters, Bjoern ;
Rao, Anjana .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (36) :14532-14537
[2]   Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors [J].
Bantscheff, Marcus ;
Eberhard, Dirk ;
Abraham, Yann ;
Bastuck, Sonja ;
Boesche, Markus ;
Hobson, Scott ;
Mathieson, Toby ;
Perrin, Jessica ;
Raida, Manfred ;
Rau, Christina ;
Reader, Valerie ;
Sweetman, Gavain ;
Bauer, Andreas ;
Bouwmeester, Tewis ;
Hopf, Carsten ;
Kruse, Ulrich ;
Neubauer, Gitte ;
Ramsden, Nigel ;
Rick, Jens ;
Kuster, Bernhard ;
Drewes, Gerard .
NATURE BIOTECHNOLOGY, 2007, 25 (09) :1035-1044
[3]   Chemoproteomic approaches to drug target identification and drug profiling [J].
Bantscheff, Marcus ;
Drewes, Gerard .
BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (06) :1973-1978
[4]   Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes [J].
Bantscheff, Marcus ;
Hopf, Carsten ;
Savitski, Mikhail M. ;
Dittmann, Antje ;
Grandi, Paola ;
Michon, Anne-Marie ;
Schlegl, Judith ;
Abraham, Yann ;
Becher, Isabelle ;
Bergamini, Giovanna ;
Boesche, Markus ;
Delling, Manja ;
Duempelfeld, Birgit ;
Eberhard, Dirk ;
Huthmacher, Carola ;
Mathieson, Toby ;
Poeckel, Daniel ;
Reader, Valerie ;
Strunk, Katja ;
Sweetman, Gavain ;
Kruse, Ulrich ;
Neubauer, Gitte ;
Ramsden, Nigel G. ;
Drewes, Gerard .
NATURE BIOTECHNOLOGY, 2011, 29 (03) :255-U124
[5]   BET Protein Function Is Required for Inflammation: Brd2 Genetic Disruption and BET Inhibitor JQ1 Impair Mouse Macrophage Inflammatory Responses [J].
Belkina, Anna C. ;
Nikolajczyk, Barbara S. ;
Denis, Gerald V. .
JOURNAL OF IMMUNOLOGY, 2013, 190 (07) :3670-3678
[6]   A selective inhibitor reveals PI3Kγ dependence of TH17 cell differentiation (vol 8, pg 576, 2012) [J].
Bergamini, Giovanna ;
Bell, Kathryn ;
Shimamura, Satoko ;
Werner, Thilo ;
Cansfield, Andrew ;
Mueller, Katrin ;
Perrin, Jessica ;
Rau, Christina ;
Ellard, Katie ;
Hopf, Carsten ;
Doce, Carola ;
Leggate, Daniel ;
Mangano, Raffaella ;
Mathieson, Toby ;
O'Mahony, Alison ;
Plavec, Ivan ;
Rharbaoui, Faiza ;
Reinhard, Friedrich ;
Savitski, Mikhail M. ;
Ramsden, Nigel ;
Hirsch, Emilio ;
Drewes, Gerard ;
Rausch, Oliver ;
Bantscheff, Marcus ;
Neubauer, Gitte .
NATURE CHEMICAL BIOLOGY, 2012, 8 (08) :737-737
[7]   Target validation using chemical probes [J].
Bunnage, Mark E. ;
Chekler, Eugene L. Piatnitski ;
Jones, Lyn H. .
NATURE CHEMICAL BIOLOGY, 2013, 9 (04) :195-199
[8]   Discovery and Characterizatlion of Small Molecule Inhibitors of the BET Family Bromodomains [J].
Chung, Chun-wa ;
Coste, Herve ;
White, Julia H. ;
Mirguet, Olivier ;
Wilde, Jonathan ;
Gosmini, Romain L. ;
Delves, Chris ;
Magny, Sylvie M. ;
Woodward, Robert ;
Hughes, Stephen A. ;
Boursier, Eric V. ;
Flynn, Helen ;
Bouillot, Anne M. ;
Bamborough, Paul ;
Brusq, Jean-Marie G. ;
Gellibert, Francoise J. ;
Jones, Emma J. ;
Riou, Alizon M. ;
Homes, Paul ;
Martin, Sandrine L. ;
Uings, Iain J. ;
Toum, Jerome ;
Clement, Catherine A. ;
Boullay, Anne-Benedicte ;
Grimley, Rachel L. ;
Blande, Florence M. ;
Prinjha, Rab K. ;
Lee, Kevin ;
Kirilovsky, Jorge ;
Nicodeme, Edwige .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (11) :3827-3838
[9]   Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia [J].
Dawson, Mark A. ;
Prinjha, Rab K. ;
Dittmann, Antje ;
Giotopoulos, George ;
Bantscheff, Marcus ;
Chan, Wai-In ;
Robson, Samuel C. ;
Chung, Chun-wa ;
Hopf, Carsten ;
Savitski, Mikhail M. ;
Huthmacher, Carola ;
Gudgin, Emma ;
Lugo, Dave ;
Beinke, Soren ;
Chapman, Trevor D. ;
Roberts, Emma J. ;
Soden, Peter E. ;
Auger, Kurt R. ;
Mirguet, Olivier ;
Doehner, Konstanze ;
Delwel, Ruud ;
Burnett, Alan K. ;
Jeffrey, Phillip ;
Drewes, Gerard ;
Lee, Kevin ;
Huntly, Brian J. P. ;
Kouzarides, Tony .
NATURE, 2011, 478 (7370) :529-533
[10]   A novel, mitogen-activated nuclear kinase is related to a Drosophila developmental regulator [J].
Denis, GV ;
Green, MR .
GENES & DEVELOPMENT, 1996, 10 (03) :261-271